Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)
3.500
+0.060 (1.74%)
At close: Feb 10, 2026
Scandinavian ChemoTech AB Market Cap
Scandinavian ChemoTech AB has a market cap or net worth of 81.7 million as of February 10, 2026. Its market cap has increased by 215.32% in one year.
Market Cap
81.70M
Enterprise Value
77.41M
Revenue
11.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.50
Market Cap Chart
Since December 6, 2016, Scandinavian ChemoTech AB's market cap has increased from 63.83M to 81.70M, an increase of 28.01%. That is a compound annual growth rate of 2.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 81.70M | -30.28% |
| Dec 30, 2025 | 117.19M | 180.45% |
| Dec 30, 2024 | 41.79M | -4.97% |
| Dec 29, 2023 | 43.97M | -27.52% |
| Dec 30, 2022 | 60.67M | -63.03% |
| Dec 30, 2021 | 164.08M | 100.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biovica International AB | 129.61M |
| Simris Group AB (PUBL) | 126.32M |
| Annexin Pharmaceuticals AB | 112.24M |
| Biosergen AB | 106.61M |
| Active Biotech AB | 101.22M |
| Alligator Bioscience AB | 96.21M |
| Spago Nanomedical AB | 83.03M |
| Alzinova AB | 73.97M |